Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.39 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.38 |
| ▸ | DGKA | P23743 | 1/20 | 0.38 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL719298 | 1.00 | MEN1 (0.42) | MEN1KMT2AMAPTLMNAPLA2G4A | |
| SCHEMBL720567 | 1.00 | MEN1 (0.42) | MEN1KMT2AMAPTLMNAPLA2G4A | |
| SCHEMBL718658 | 1.00 | MEN1 (0.42) | MEN1KMT2AMAPTLMNAPLA2G4A | |
| SCHEMBL720697 | 1.00 | MEN1 (0.42) | MEN1KMT2AMAPTLMNAPLA2G4A | |
| SCHEMBL720859 | 0.92 | MEN1 (0.43) | MEN1KMT2AMAPTLMNAPLA2G4A | |
| SCHEMBL723053 | 0.92 | MEN1 (0.43) | MEN1KMT2AMAPTLMNAPLA2G4A | |
| SCHEMBL10119660 | 0.89 | L3MBTL1 (0.47) | MEN1KMT2AMAPTLMNAPLA2G4A | |
| SCHEMBL10119667 | 0.89 | L3MBTL1 (0.47) | MEN1KMT2AMAPTLMNAPLA2G4A | |
| SCHEMBL722869 | 0.89 | LMNA (0.46) | MEN1KMT2AMAPTLMNAFFAR4 | |
| SCHEMBL15315011 | 0.88 | MEN1 (0.41) | MEN1KMT2AMAPTLMNAPLA2G4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9253978-B2 | Sulfoperoxycarboxylic acids, their preparation and methods of use as bleaching and antimicrobial agents | Ecolab USA, Inc. (US) | 2016-02-09 | — | — | US | disclosed |
| US-20130274334-A1 | SULFOPEROXYCARBOXYLIC ACIDS, THEIR PREPARATION AND METHODS OF USE AS BLEACHING AND ANTIMICROBIAL AGENTS | ECOLAB USA INC (US) | 2013-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130274334-A1 | SULFOPEROXYCARBOXYLIC ACIDS, THEIR PREPARATION AND METHODS OF USE AS BLEACHING AND ANTIMICROBIAL AGENTS | GPX4, PRDX1, PRDX4 | MEN1 4879/4885KMT2A 3506/4885MAPT 4882/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.